Teachers Advisors LLC cut its holdings in shares of Vitamin Shoppe, Inc (NYSE:VSI) by 4.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,759 shares of the specialty retailer’s stock after selling 2,932 shares during the period. Teachers Advisors LLC owned about 0.26% of Vitamin Shoppe worth $708,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. grew its position in Vitamin Shoppe by 34.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 262,123 shares of the specialty retailer’s stock worth $3,054,000 after acquiring an additional 67,362 shares during the last quarter. Aperio Group LLC bought a new stake in Vitamin Shoppe during the 2nd quarter worth approximately $402,000. Russell Investments Group Ltd. grew its position in Vitamin Shoppe by 16.7% during the 2nd quarter. Russell Investments Group Ltd. now owns 26,788 shares of the specialty retailer’s stock worth $312,000 after acquiring an additional 3,839 shares during the last quarter. Legal & General Group Plc grew its position in Vitamin Shoppe by 9.3% during the 2nd quarter. Legal & General Group Plc now owns 44,555 shares of the specialty retailer’s stock worth $518,000 after acquiring an additional 3,789 shares during the last quarter. Finally, Principal Financial Group Inc. grew its position in Vitamin Shoppe by 3.7% during the 1st quarter. Principal Financial Group Inc. now owns 181,564 shares of the specialty retailer’s stock worth $3,659,000 after acquiring an additional 6,408 shares during the last quarter. Institutional investors and hedge funds own 98.39% of the company’s stock.

Vitamin Shoppe, Inc (NYSE:VSI) opened at $4.30 on Wednesday. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.27 and a quick ratio of 0.34. The company has a market capitalization of $101.70, a price-to-earnings ratio of 2.95 and a beta of 0.74. Vitamin Shoppe, Inc has a 12-month low of $4.25 and a 12-month high of $26.60.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.39 by ($0.16). The company had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same period last year, the company earned $0.55 EPS. equities research analysts predict that Vitamin Shoppe, Inc will post 0.72 earnings per share for the current fiscal year.

In related news, Director John D. Bowlin purchased 40,000 shares of the business’s stock in a transaction dated Friday, August 25th. The shares were bought at an average price of $5.50 per share, with a total value of $220,000.00. Following the purchase, the director now directly owns 56,028 shares in the company, valued at approximately $308,154. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.07% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Vitamin Shoppe, Inc (VSI) Shares Sold by Teachers Advisors LLC” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/08/vitamin-shoppe-inc-vsi-shares-sold-by-teachers-advisors-llc.html.

VSI has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 18th. BidaskClub lowered Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Barclays PLC decreased their price target on Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 10th. Deutsche Bank AG reiterated a “hold” rating and issued a $7.00 price objective (down from $14.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Finally, Goldman Sachs Group, Inc. (The) reiterated a “sell” rating and issued a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Four research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company’s stock. Vitamin Shoppe currently has an average rating of “Hold” and an average target price of $6.30.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.